SCHEMBL21156347

SCHEMBL21156347

CNC(=O)C(C)/C=C(/Cc1ccccc1)OC

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP3A4 P08684 2/20 0.46
TSHR P16473 1/20 0.44
KLK7 P49862 3/20 0.43
LTA4H P09960 1/20 0.43
EPHX2 P34913 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
RAB9A P51151 3/20 0.41
MAPT P10636 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23188915 0.84 TSHR (0.45) ALDH1A1TSHRLTA4HSMN1; SMN2LMNA
SCHEMBL11310670 0.75 ALDH1A1 (0.44) ALDH1A1CYP3A4TSHREPHX2MEN1
SCHEMBL12591107 0.71 CES2 (0.45) ALDH1A1TSHREPHX2SMN1; SMN2LMNA
SCHEMBL22710157 0.71 ALDH1A1 (0.39) ALDH1A1CYP3A4TSHRSMN1; SMN2LMNA
SCHEMBL19980206 0.71 TSHR (0.41) ALDH1A1TSHREPHX2SMN1; SMN2LMNA
SCHEMBL14336343 0.70 LTA4H (0.48) ALDH1A1CYP3A4TSHRLTA4HSMN1; SMN2
SCHEMBL7298648 0.70 ALDH1A1 (0.44) ALDH1A1TSHREPHX2SMN1; SMN2LMNA
SCHEMBL13555325 0.70 LTA4H (0.48) ALDH1A1CYP3A4TSHRLTA4HSMN1; SMN2
SCHEMBL7298652 0.70 ALDH1A1 (0.44) ALDH1A1TSHREPHX2SMN1; SMN2LMNA
SCHEMBL23188930 0.70 TSHR (0.46) ALDH1A1TSHRSMN1; SMN2LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3508484-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-07-10 EP disclosed